Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AGTR1 | P30556 | 4/20 | 0.47 |
| ▸ | AGTR2 | P50052 | 2/20 | 0.47 |
| ▸ | PPARG | P37231 | 3/20 | 0.44 |
| ▸ | FNTA | P49354 | 1/20 | 0.44 |
| ▸ | FNTB | P49356 | 1/20 | 0.44 |
| ▸ | PGGT1B | P53609 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17425121 | 0.81 | CYP11B1 (0.53) | — | |
| SCHEMBL683433 | 0.81 | AGTR1 (0.54) | AGTR1AGTR2 | |
| SCHEMBL1839727 | 0.80 | CYP11B1 (0.44) | PPARGFNTAFNTB | |
| SCHEMBL1841655 | 0.76 | FNTA (0.36) | FNTAFNTBPGGT1B | |
| SCHEMBL1843490 | 0.76 | PKM (0.40) | FNTAFNTBPGGT1B | |
| SCHEMBL1844573 | 0.76 | SOS1 (0.59) | AGTR1AGTR2PPARG | |
| SCHEMBL1839643 | 0.75 | TAAR1 (0.48) | AGTR1AGTR2 | |
| SCHEMBL27393196 | 0.74 | AGTR1 (0.47) | AGTR1AGTR2PPARG | |
| SCHEMBL8396472 | 0.71 | CYP11B1 (0.67) | AGTR1AGTR2PPARG | |
| SCHEMBL1242 | 0.71 | PKM (0.71) | AGTR1AGTR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8236843-B2 | Anti inflammatory compounds | ELDER PHARMACEUTICALS LTD. (IN) | 2012-08-07 | — | — | US | claimed |
| US-20110263543-A1 | ANTI INFLAMMATORY COMPOUNDS | ELDER PHARMACEUTICALS LTD. (IN) | 2011-10-27 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110263543-A1 | ANTI INFLAMMATORY COMPOUNDS | IL1B, LITAF, IL6 | AGTR1 1702/4885AGTR2 1149/4885PPARG 85/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.